Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-018719

Director acquired 1,112 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

ASELAGE STEVE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-06-01 Grant or award : show line 1 in the form +1,112 $4.50 $4,998 26,204 D
Loading xslF345X03/form4.xml…